Andere Sprachen Moderna, Inc.

Aktien

A2N9D9

US60770K1079

MRNA

Pharmazeutika

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 08.05.2026			% 5 Tage	Veränd. 1. Jan.
54,35 ^USD	+11,97 %		+19,79 %	+84,30 %

06.05.	Modernas mRNA-Grippeimpfstoff übertrifft Standardvakzin in Phase-III-Studie	RE
06.05.	Novavax übertrifft Umsatzprognosen für das erste Quartal dank starker Impfstoff-Deals	RE

Andere Sprachen

08.05.	Technologie trekt S&P 500 en Nasdaq naar nieuwe records
06.05.	Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
06.05.	Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial
06.05.	Novavax beats first-quarter revenue estimates on strength in vaccine deals
05.05.	US FDA blocked publication of COVID, shingles vaccine safety studies
04.05.	Vertex Pharmaceuticals Ends Study of Cystic Fibrosis Drug Over Tolerability Issues
04.05.	Moderna : Presentation (Moderna 1Q26 Earnings Presentation FINAL)
04.05.	Moderna Sees Progress Across Cancer Vaccine, Infectious Disease Pipeline, RBC Says
04.05.	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower
01.05.	Health Care Up as Obesity-Drug Makers Regain Momentum -- Health Care Roundup
01.05.	Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.
01.05.	Moderna, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
01.05.	Wall Street scherpt records verder aan
01.05.	Moderna : Transcript (MRNA USQ Transcript 2026 05 01 1)
01.05.	Moderna Maintains 2026 Revenue Growth Outlook as First-Quarter Results Beat Estimates
01.05.	Wall Street en hausse pour débuter le mois
01.05.	Exchange-Traded Funds Higher, Equity Futures Mixed Amid Continued Earnings Results
01.05.	Top Premarket Gainers
01.05.	Moderna: CA au T1 au-dessus des attentes avec les ventes internationales de vaccins contre la COVID-19
01.05.	Stocks Mostly Up Pre-Bell as Investors Await More Corporate Earnings
01.05.	Moderna : Earnings Presentation (Moderna 1Q26 Earnings Presentation FINAL)
01.05.	Moderna Q1 Loss Widens, Revenue Rises; Reiterates 2026 Revenue Outlook
01.05.	Moderna: Q1 Earnings Snapshot
01.05.	Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss
01.05.	Moderna reports Q1 EPS of $ -3.40